Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials
- 1 September 2014
- journal article
- research article
- Published by Elsevier BV in The Lancet Respiratory Medicine
- Vol. 2 (9), 738-749
- https://doi.org/10.1016/s2213-2600(14)70165-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Treatment of lung infection in patients with cystic fibrosis: Current and future strategiesJournal of Cystic Fibrosis, 2012
- BronchiectasisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2008
- Microbiologic follow-up study in adult bronchiectasisRespiratory Medicine, 2007
- Effect of long‐term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsisInternal Medicine Journal, 2007
- Prolonged antibiotics for purulent bronchiectasis in children and adultsPublished by Wiley ,2006
- Addition of Inhaled Tobramycin to Ciprofloxacin for Acute Exacerbations of Pseudomonas aeruginosa Infection in Adult BronchiectasisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2006
- A Pilot Study of the Safety and Efficacy of Tobramycin Solution for Inhalation in Patients With Severe Bronchiectasis*Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2005
- Inhaled Tobramycin in Non—Cystic Fibrosis Patients with Bronchiectasis and Chronic Bronchial Infection withPseudomonas AeruginosaAnnals of Pharmacotherapy, 2005
- BronchiectasisThe New England Journal of Medicine, 2002
- Tobramycin Solution for Inhalation Reduces Sputum Pseudomonas aeruginosa Density in BronchiectasisAmerican Journal of Respiratory and Critical Care Medicine, 2000